−44.10 M USD
11.99 M USD
About Beta Bionics, Inc.
Sector
Industry
CEO
Sean Thomas Saint
Website
Headquarters
Irvine
Founded
2015
FIGI
BBG00JNGG9Q2
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BBNX is 23.81 USD — it has increased by 0.76% in the past 24 hours. Watch Beta Bionics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Beta Bionics, Inc. stocks are traded under the ticker BBNX.
BBNX stock has risen by 8.23% compared to the previous week, the month change is a 8.23% rise, over the last year Beta Bionics, Inc. has showed a 8.23% increase.
Yes, you can track Beta Bionics, Inc. financials in yearly and quarterly reports right on TradingView.
BBNX net income for the last quarter is −9.74 M USD, while the quarter before that showed −18.85 M USD of net income which accounts for 48.34% change. Track more Beta Bionics, Inc. financial stats to get the full picture.
No, BBNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 1, 2025, the company has 277.00 employees. See our rating of the largest employees — is Beta Bionics, Inc. on this list?
Like other stocks, BBNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Beta Bionics, Inc. stock right from TradingView charts — choose your broker and connect to your account.